ArticleNeuroendocrinology2017

Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease.

Helma Freitag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.